Press releases | Deinove

28.09.2017

2017 half-year consolidated results: stability of net loss major progress on R&D programs in health, nutrition and cosmetics

Cash position: +€6.6m at June 30, 2017 compared to +€9.3m at December 31, 2016. Half-year net loss of DEINOVE Group (composed of DEINOVE...

12.09.2017

The AGIR project (Antibiotics against Resistant Infectious Germs), carried out by the DEINOVE group and the Charles Viollette Institute,...

24.07.2017

Sébastien Enault brings to the Company a proven track record in the development of collaborations in the pharmaceutical field and, in...

05.07.2017

Phase I of the program selected the first carotenoid molecule to be produced on an industrial scale in 2018. The yields obtained in 20-...

31.05.2017

The partnership aims to develop and market new natural additives for animal feed. The first phase led to the successful selection of...

23.05.2017

PhD in molecular pharmacology, expert in the development of new molecules and their formulation, Dr. Gaudriault has spent his entire career...

16.05.2017

Hervé Brailly, co-founder and executive of Innate Pharma SA [IPH], one of the world's leading immuno-oncology specialists and one of the...

10.05.2017

Focuses on the use of Deinococcus as a source of feed ingredients Issued in China, the world's leading country for livestock farming...

19.04.2017

The 2 nd step of the project has been completed: the effectiveness and bioavailability of the ingredients developed by Deinove have been...

30.03.2017

Cash position of €9.3 million, and net loss down 1% to €6.3 million Strategic focus on high value-added applications in the healthcare,...